Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 624
2021 495
2022 181
2023 80
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

1,234 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 and lung pathologies.
Purohit D, Ahirwar AK, Sakarde A, Asia P, Gopal N. Purohit D, et al. Horm Mol Biol Clin Investig. 2021 Aug 2;42(4):435-443. doi: 10.1515/hmbci-2020-0096. Horm Mol Biol Clin Investig. 2021. PMID: 34333882 Review.
COVID-19 is a global emergency with over 10 million cases and over 500, 000 deaths worldwide. The SARS CoV-2 is a RNA virus belonging to the family coronaviridae. ...
COVID-19 is a global emergency with over 10 million cases and over 500, 000 deaths worldwide. The SARS CoV …
COVID-19 challenges and its therapeutics.
Rehman SU, Rehman SU, Yoo HH. Rehman SU, et al. Biomed Pharmacother. 2021 Oct;142:112015. doi: 10.1016/j.biopha.2021.112015. Epub 2021 Aug 5. Biomed Pharmacother. 2021. PMID: 34388532 Free PMC article. Review.
COVID-19, an infectious disease, has emerged as one of the leading causes of death worldwide, making it one of the severe public health issues in recent decades. nCoV, the novel SARS coronavirus that causes COVID-19, has brought to …
COVID-19, an infectious disease, has emerged as one of the leading causes of death worldwide, making it one of the seve …
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment.
Drożdżal S, Rosik J, Lechowicz K, Machaj F, Szostak B, Przybyciński J, Lorzadeh S, Kotfis K, Ghavami S, Łos MJ. Drożdżal S, et al. Drug Resist Updat. 2021 Dec;59:100794. doi: 10.1016/j.drup.2021.100794. Epub 2021 Dec 9. Drug Resist Updat. 2021. PMID: 34991982 Free PMC article. Review.
Various agents were initially proclaimed to be effective against SARS-CoV-2, the etiological agent of COVID-19. Hydroxychloroquine, lopinavir/ritonavir, and ribavirin are all examples of therapeutic agents, whose efficacy against COVID …
Various agents were initially proclaimed to be effective against SARS-CoV-2, the etiological agent of COVID-1 …
Neutrophil autophagy and NETosis in COVID-19: perspectives.
Zhang R, Sun C, Han Y, Huang L, Sheng H, Wang J, Zhang Y, Lai J, Yuan J, Chen X, Jiang C, Wu F, Wang J, Fan X, Wang J. Zhang R, et al. Autophagy. 2023 Mar;19(3):758-767. doi: 10.1080/15548627.2022.2099206. Epub 2022 Aug 11. Autophagy. 2023. PMID: 35951555 Free PMC article. Review.
The SARS-CoV-2 pathogen is the cause of various systemic diseases, mainly acute pneumonia. ...This review keeps up with the latest research on COVID-19 from neutrophil autophagy and NETosis with a new perspective, which can guide the urgent deve …
The SARS-CoV-2 pathogen is the cause of various systemic diseases, mainly acute pneumonia. ...This review keeps up with …
Emerging treatment strategies for COVID-19 infection.
Gavriatopoulou M, Ntanasis-Stathopoulos I, Korompoki E, Fotiou D, Migkou M, Tzanninis IG, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA. Gavriatopoulou M, et al. Clin Exp Med. 2021 May;21(2):167-179. doi: 10.1007/s10238-020-00671-y. Epub 2020 Oct 30. Clin Exp Med. 2021. PMID: 33128197 Free PMC article. Review.
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused by SARS-CoV-2 characterized as …
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and has led to a w …
ESCMID COVID-19 living guidelines: drug treatment and clinical management.
Bartoletti M, Azap O, Barac A, Bussini L, Ergonul O, Krause R, Paño-Pardo JR, Power NR, Sibani M, Szabo BG, Tsiodras S, Verweij PE, Zollner-Schwetz I, Rodríguez-Baño J. Bartoletti M, et al. Clin Microbiol Infect. 2022 Feb;28(2):222-238. doi: 10.1016/j.cmi.2021.11.007. Epub 2021 Nov 22. Clin Microbiol Infect. 2022. PMID: 34823008 Free PMC article.
SCOPE: In January 2021, the ESCMID Executive Committee decided to launch a new initiative to develop ESCMID guidelines on several COVID-19-related issues, including treatment of COVID-19. METHODS: An ESCMID COVID-19 guidelines task force …
SCOPE: In January 2021, the ESCMID Executive Committee decided to launch a new initiative to develop ESCMID guidelines on several COVID …
An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination.
Khade SM, Yabaji SM, Srivastava J. Khade SM, et al. Prep Biochem Biotechnol. 2021;51(7):650-658. doi: 10.1080/10826068.2020.1848869. Epub 2020 Nov 23. Prep Biochem Biotechnol. 2021. PMID: 33226885 Review.
The causative agent of novel coronavirus disease (COVID-19) is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 possesses RNA as a genetic material …
The causative agent of novel coronavirus disease (COVID-19) is severe acute respiratory syndrom …
Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study.
Hippisley-Cox J, Coupland CA, Mehta N, Keogh RH, Diaz-Ordaz K, Khunti K, Lyons RA, Kee F, Sheikh A, Rahman S, Valabhji J, Harrison EM, Sellen P, Haq N, Semple MG, Johnson PWM, Hayward A, Nguyen-Van-Tam JS. Hippisley-Cox J, et al. BMJ. 2021 Sep 17;374:n2244. doi: 10.1136/bmj.n2244. BMJ. 2021. PMID: 34535466 Free PMC article.
DESIGN: Prospective, population based cohort study using the QResearch database linked to data on covid-19 vaccination, SARS-CoV-2 results, hospital admissions, systemic anticancer treatment, radiotherapy, and the national death and cance …
DESIGN: Prospective, population based cohort study using the QResearch database linked to data on covid-19 vaccination, SAR …
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
Gasmi A, Peana M, Noor S, Lysiuk R, Menzel A, Gasmi Benahmed A, Bjørklund G. Gasmi A, et al. Appl Microbiol Biotechnol. 2021 Feb;105(4):1333-1343. doi: 10.1007/s00253-021-11094-4. Epub 2021 Jan 30. Appl Microbiol Biotechnol. 2021. PMID: 33515285 Free PMC article. Review.
The anti-malarial drugs chloroquine (CQ) and hydroxychloroquine (HCQ) have been suggested as promising agents against the new coronavirus SARS-CoV-2 that induces COVID-19 and as a possible therapy for shortening the duration of the …
The anti-malarial drugs chloroquine (CQ) and hydroxychloroquine (HCQ) have been suggested as promising agents against the new coro …
Pan-American Guidelines for the treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API).
Barbosa AN, Chebabo A, Starling C, Pérez C, Cunha CA, de Luna D, Nunes EP, Zambrano G, Ferreira JC, Croda J, Falavigna M, Gomes-da-Silva MM, Thormann M, Cimerman S, Parahiba SM, Tanni S, Bernardo WM, Rodriguez-Morales AJ. Barbosa AN, et al. Ann Clin Microbiol Antimicrob. 2023 Aug 7;22(1):67. doi: 10.1186/s12941-023-00623-w. Ann Clin Microbiol Antimicrob. 2023. PMID: 37550690 Free PMC article. Review.
BACKGROUND: Since the beginning of the COVID-19 pandemic, therapeutic options for treating COVID-19 have been investigated at different stages of clinical manifestations. ...Questions were formulated regarding prophylaxis and treatment of COVID- …
BACKGROUND: Since the beginning of the COVID-19 pandemic, therapeutic options for treating COVID-19 have been in …
1,234 results